仁和药业(000650) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥786,304,880.57, representing a decrease of 30.83% compared to the same period last year[2]. - Net profit attributable to shareholders for Q3 2024 was ¥78,501,931.30, down 57.30% year-on-year[2]. - The net profit after deducting non-recurring gains and losses was ¥51,143,878.60, a decline of 67.00% compared to the previous year[2]. - Total operating revenue for the third quarter was CNY 3,150,637,679.36, a decrease of 17.5% compared to CNY 3,818,691,932.62 in the same period last year[13]. - The net profit for Q3 2024 was CNY 514,902,723.31, a decrease of 21.1% compared to CNY 652,593,697.28 in Q3 2023[14]. - The total profit for the period was CNY 683,366,510.37, down from CNY 858,734,254.05, a decrease of 20.4%[14]. - The basic earnings per share for Q3 2024 was CNY 0.2969, compared to CNY 0.3860 in Q3 2023, representing a decline of 23.1%[15]. - The company reported a total comprehensive income of CNY 514,902,723.31, down from CNY 652,593,697.28, reflecting a decrease of 21.1%[15]. Assets and Liabilities - Total assets at the end of the reporting period were ¥7,635,384,565.02, an increase of 2.56% from the end of the previous year[2]. - Total assets reached CNY 7,635,384,565.02, up from CNY 7,444,681,386.84 at the beginning of the period, indicating a growth of 2.6%[12]. - Non-current assets totaled CNY 2,989,033,782.13, an increase of 4.5% from CNY 2,860,970,209.82[12]. - Total liabilities decreased slightly to CNY 788,253,801.10 from CNY 790,180,602.21, a reduction of 0.2%[12]. - The company's equity attributable to shareholders increased to CNY 6,097,669,652.61 from CNY 5,993,036,906.06, reflecting a growth of 1.7%[12]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥298,363,941.70, an increase of 41.48% compared to the same period last year[2]. - The net cash flow from operating activities increased by 41.48% to ¥298,363,941.70 compared to the previous period, primarily due to higher government subsidies and lower operating expenses[6]. - The net cash flow from operating activities for Q3 2024 was approximately ¥298.36 million, an increase from ¥210.88 million in Q3 2023, representing a growth of 41.4%[17]. - The company's cash outflow from operating activities totaled approximately ¥3.25 billion, down from ¥3.77 billion in the same period last year, a decrease of 13.7%[17]. - The net cash flow from investment activities was negative at -¥2,172,121,641.49, a 41.13% increase in outflows compared to the previous period, mainly due to higher investments in financial products and long-term large deposits[6]. - The net cash flow from investment activities was negative at approximately -¥2.17 billion, worsening from -¥1.54 billion in Q3 2023[17]. - The total cash inflow from investment activities reached approximately ¥4.97 billion, up from ¥3.58 billion in the same period last year, indicating a growth of 38.9%[17]. Income and Expenses - Interest income decreased by 44.80% to ¥11,679,823.65, mainly due to a decline in certificate of deposit products and interest rates[6]. - Other income rose significantly by 110.51% to ¥112,551,014.14, attributed to increased government subsidies received compared to the same period last year[6]. - Investment income decreased by 60.08% to ¥21,523,313.36, primarily due to lower returns from financial products and recognized investment losses[6]. - The company's sales expenses were CNY 359,767,057.72, down from CNY 416,203,819.41, indicating a decrease of 13.6%[14]. - Research and development expenses decreased to CNY 23,201,544.61 from CNY 29,412,725.43, a reduction of 21.1% year-over-year[14]. - The financial expenses showed a significant improvement, with a net income of CNY -9,816,450.73 compared to CNY -18,093,820.98, indicating a reduction in financial costs[14]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 102,612[8]. - The largest shareholder, Renhe Group, holds 23.24% of the shares, amounting to 325,299,386 shares[8].